After further adjusting age, sex, PS score, and clinical stage in the logistic regression model, it can also be found that the association between average vessel length and treatment unresponsiveness (SD + PD) remained marginally statistically significant, suggesting that the enhanced pro‐angiogenic capacity of CD33 + MDSCs may represent a risk factor for treatment unresponsiveness in SCLC (Table 3 ). 3.4.
← all excerpts
The Promoting Angiogenesis and Its Clinical Significance of CD33<sup>+</sup>Myeloid Derived Suppressor Cells Derived From Small Cell Lung Cancer.
1
—
—